Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.
The exact cause of endometrial carcinoma remains unknown, although several risk factors have been identified. Possessing one of these risk factors does not mean that a woman will develop endometrial cancer but rather that her risk of developing endometrial cancer is higher than that of another woman without the risk factor. Risk factors for endometrial cancer include the following:
Obesity: Women who
are more than 50 pounds over ideal weight have a 10-times greater risk of
developing endometrial cancer than women of ideal weight. Body fat produces
estrogen, and women with excess fat have a higher level of estrogen than women
without excess fat. The higher level of estrogen is believed to increase the
risk of cancer.
No pregnancies: Women who have never been pregnant have a
to three-times higher risk than women who have been pregnant.
Early puberty: Women who
begin their periods before 12 years of age are at an increased risk. Early
puberty increases the number of years that the endometrium is exposed to
Late menopause: Women who go through menopause after
52 years of age are at a higher risk of developing endometrial cancer than women
who go through menopause earlier in life. Like early puberty, late menopause
increases the number of years that the endometrium is exposed to estrogen.
Treatment with unopposed estrogen: The risk of developing endometrial cancer is increased by several times in women who take estrogen replacement therapy without added progesterone.
High level of estrogen: Women who have a high level of unopposed estrogen in the body are also at an increased risk. Several different conditions, such as polycystic ovarian disease, can
cause a woman to have a high unopposed estrogen level.
Treatment with tamoxifen: Women who have been treated with tamoxifen, a drug used to prevent and treat breast cancer, may
have a slightly increased risk of developing endometrial cancer.
Other cancers: Cancers of the breast, ovary, and colon are linked with
an increased risk of endometrial cancer.
Family history: Women who have a close relative with endometrial cancer have an increased risk of the disease.
The use of combination oral contraceptives (birth control pills)
decreases the risk of developing endometrial cancer.
Women who use oral contraceptives at some time have
half the risk of developing endometrial cancer as women who have never used
This protection occurs in women who have used oral
contraceptives for at least 12 months.
The protection continues for at least 10 years after oral contraceptive use. The protection is most notable for women who have never been pregnant.